H. L. Ploegh, H. T. Orr, and J. L. Strominger, Major histocompatibility antigens: the human (HLA-A, -B, -C) and murine (H-2K, H-2D) class I molecules, Cell, vol.24, pp.287-299, 1981.

C. A. O'callaghan, J. I. Bell, ;. Hla-e, and H. Hla-f-and, Structure and function of the human MHC class Ib molecules, Immunol. Rev, vol.163, pp.129-138, 1998.

R. Yaneva, C. Schneeweiss, M. Zacharias, and S. Springer, Peptide binding to MHC class I and II proteins: new avenues from new methods, Mol. Immunol, vol.47, pp.649-657, 2010.

R. N. Germain and I. Stefanová, The dynamics of T cell receptor signaling: complex orchestration and the key roles of tempo and cooperation, Annu. Rev. Immunol, vol.17, pp.467-522, 1999.

A. Moretta, R. Biassoni, C. Bottino, M. C. Mingari, and L. Moretta, Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis, Immunol. Today, vol.21, pp.228-234, 2000.

M. Campoli and S. Ferrone, Tumor escape mechanisms: potential role of soluble HLA antigens and NK cells activating ligands, Tissue Antigens, vol.72, pp.321-334, 2008.

J. C. Mcdonald and I. Adamashvili, Soluble HLA: a review of the literature, Hum. Immunol, vol.59, pp.387-403, 1998.

I. Adamashvili, R. E. Kelley, T. Pressly, and J. C. Mcdonald, Soluble HLA: patterns of expression in normal subjects, autoimmune diseases, and transplant recipients, Rheumatol. Int, vol.25, pp.491-500, 2005.

W. B. Tabayoyong and N. Zavazava, Soluble HLA revisited, Leuk. Res, vol.31, pp.121-125, 2007.

R. Bahri, F. Hirsch, A. Josse, N. Rouas-freiss, N. Bidere et al., Soluble HLA-G inhibits cell cycle progression in human alloreactive T lymphocytes, J. Immunol, vol.176, pp.1331-1339, 2006.

P. Contini, M. Ghio, A. Poggi, G. Filaci, F. Indiveri et al., Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation, Eur. J. Immunol, vol.33, pp.125-134, 2003.

J. Delon, C. Grégoire, B. Malissen, S. Darche, F. Lemaître et al., CD8 expression allows T cell signaling by monomeric peptide-MHC complexes, Immunity, vol.9, pp.467-473, 1998.

S. Fournel, M. Aguerre-girr, X. Huc, F. Lenfant, A. Alam et al., Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8, J. Immunol, vol.164, pp.6100-6104, 2000.

A. Naji, A. Durrbach, E. D. Carosella, and N. Rouas-freiss, Soluble HLA-G and HLA-G1 expressing antigen-presenting cells inhibit T-cell alloproliferation through ILT-2/ILT-4/FasL-mediated pathways, Hum. Immunol, vol.68, pp.233-239, 2007.

G. M. Spaggiari, P. Contini, R. Carosio, M. Arvigo, M. Ghio et al., Soluble HLA class I molecules induce natural killer cell apoptosis through the engagement of CD8: evidence for a negative regulation exerted by members of the inhibitory receptor superfamily, Blood, vol.99, pp.1706-1714, 2002.

G. M. Spaggiari, P. Contini, A. Dondero, R. Carosio, F. Puppo et al., Soluble HLA class I induces NK cell apoptosis upon the engagement of killer-activating HLA class I receptors through FasL-Fas interaction, Blood, vol.100, pp.4098-4107, 2002.

Q. Ge, J. D. Stone, M. T. Thompson, J. R. Cochran, M. Rushe et al., Soluble peptide-MHC monomers cause activation of CD8+ T cells through transfer of the peptide to T cell MHC molecules, Proc. Natl. Acad. Sci. USA, vol.99, pp.13729-13734, 2002.

E. Schott, N. Bertho, Q. Ge, M. M. Maurice, and H. L. Ploegh, Class I negative CD8 T cells reveal the confounding role of peptide-transfer onto CD8 T cells stimulated with soluble H2-Kb molecules, Proc. Natl. Acad. Sci. USA, vol.99, pp.13735-13740, 2002.

S. Coupel, A. Moreau, M. Hamidou, V. Horejsi, J. P. Soulillou et al., Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation, Blood, vol.109, pp.2806-2814, 2007.

M. Allard, R. Oger, V. Vignard, J. M. Percier, G. Fregni et al., Serum soluble HLA-E in melanoma: a new potential immune-related marker in cancer, PLoS ONE, vol.6, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-01234644

L. Derré, M. Corvaisier, B. Charreau, A. Moreau, E. Godefroy et al., Expression and release of HLA-E by melanoma cells and melanocytes: potential impact on the response of cytotoxic effector cells, J. Immunol, vol.177, pp.3100-3107, 2006.

F. Morandi, C. Venturi, R. Rizzo, M. Castellazzi, E. Baldi et al., Intrathecal soluble HLA-E correlates with disease activity in patients with multiple sclerosis and may cooperate with soluble HLA-G in the resolution of neuroinflammation, J. Neuroimmune Pharmacol, vol.8, pp.944-955, 2013.

M. Allard, P. Tonnerre, S. Nedellec, R. Oger, A. Morice et al., HLA-E-restricted crossrecognition of allogeneic endothelial cells by CMV-associated CD8 T cells: a potential risk factor following transplantation, PLoS ONE, vol.7, p.50951, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-01726990

N. Gervois, N. Labarriere, S. L. Guiner, M. C. Pandolfino, J. F. Fonteneau et al., High avidity melanomareactive cytotoxic T lymphocytes are efficiently induced from peripheral blood lymphocytes on stimulation by peptide-pulsed melanoma cells, Clin. Cancer Res, vol.6, pp.1459-1467, 2000.

Y. Guilloux, S. Lucas, V. G. Brichard, A. Van-pel, C. Viret et al., A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene, J. Exp. Med, vol.183, pp.1173-1183, 1996.

D. Valmori, J. F. Fonteneau, C. M. Lizana, N. Gervois, D. Liénard et al., Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues, J. Immunol, vol.160, pp.1750-1758, 1998.

C. Cerboni, M. Mousavi-jazi, H. Wakiguchi, E. Carbone, K. Kärre et al., Synergistic effect of IFN-gamma and human cytomegalovirus protein UL40 in the HLA-E-dependent protection from NK cellmediated cytotoxicity, Eur. J. Immunol, vol.31, pp.2926-2935, 2001.

P. Tomasec, V. M. Braud, C. Rickards, M. B. Powell, B. P. Mcsharry et al., Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40, Science, vol.287, p.1031, 2000.

Y. Takamiya, C. Schönbach, K. Nokihara, M. Yamaguchi, S. Ferrone et al., HLA-B*3501-peptide interactions: role of anchor residues of peptides in their binding to HLA-B*3501 molecules, Int. Immunol, vol.6, pp.255-261, 1994.

M. Bodinier, M. A. Peyrat, C. Tournay, F. Davodeau, F. Romagne et al., Efficient detection and immunomagnetic sorting of specific T cells using multimers of MHC class I and peptide with reduced CD8 binding, Nat. Med, vol.6, pp.707-710, 2000.

E. Schott and H. L. Ploegh, Mouse MHC class I tetramers that are unable to bind to CD8 reveal the need for CD8 engagement in order to activate naive CD8 T cells, Eur. J. Immunol, vol.32, pp.3425-3434, 2002.

D. N. Garboczi, D. T. Hung, and D. C. Wiley, HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides, Proc. Natl. Acad. Sci, vol.89, pp.3429-3433, 1992.

T. Hansen, Y. Y. Yu, and D. H. Fremont, Preparation of stable single-chain trimers engineered with peptide, beta2 microglobulin, and MHC heavy chain, Curr. Protoc. Immunol, vol.17, 2009.

J. Goldstein, H. Mostowsky, J. Tung, H. Hon, M. Brunswick et al., Naive alloreactive CD8 T cells are activated by purified major histocompatibility complex class I and antigenic peptide, Eur. J. Immunol, vol.27, pp.871-878, 1997.

Y. Sykulev, M. Joo, I. Vturina, T. J. Tsomides, and H. N. Eisen, Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response, Immunity, vol.4, pp.565-571, 1996.